Progestogen levels, progesterone receptor gene polymorphisms, and mammographic density changes: results from the Postmenopausal Estrogen/Progestin Interventions Mammographic Density Study.

نویسندگان

  • Eunjung Lee
  • Sue A Ingles
  • David Van Den Berg
  • Wei Wang
  • Chris Lavallee
  • Mei-Hua Huang
  • Carolyn J Crandall
  • Frank Z Stanczyk
  • Gail A Greendale
  • Giske Ursin
چکیده

OBJECTIVE Estrogen plus progestin therapy (EPT) in postmenopausal women increases breast cancer risk and mammographic density to a higher extent than does estrogen therapy alone. Data from the randomized placebo-controlled Postmenopausal Estrogen/Progestinv Interventions trial showed that EPT-induced increases in serum estrone and estrone sulfate levels were positively correlated with increases in mammographic density. Here, after adjusting for serum estrone and estrone sulfate levels, we investigated the roles of posttreatment serum progestogen increase and of progesterone receptor gene (PGR) genetic variations on changes in mammographic density. METHODS We measured the percent mammographic density and serum progestogen levels in 280 Postmenopausal Estrogen/Progestin Interventions trial participants randomized to EPT treatment. Analyses of genetic variations in PGR were limited to 260 white women for whom we successfully obtained PGR genotypes. We used linear regression analyses to determine how an increase in progestogen levels and PGR genetic variation influenced mammographic density change after EPT. RESULTS The increase in posttreatment serum progestogen level was positively associated with greater increases in mammographic density after adjustment for covariates (P trend = 0.044). Compared with women in the lowest quartile of serum progestogen level, women in the highest quartile experienced a 3.5% greater increase in mammographic density (P = 0.046). We did not find a strong indication that genetic variation in PGR was associated with mammographic density increase or modified the association with serum progestogen; however, confidence in these null findings is constrained by our small sample size. CONCLUSIONS Our results suggest that higher serum progestogen levels resulting from EPT treatment lead to greater increases in mammographic density.

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Effects of estrogen and estrogen-progestin on mammographic parenchymal density. Postmenopausal Estrogen/Progestin Interventions (PEPI) Investigators.

BACKGROUND In longitudinal studies, greater mammographic density is associated with an increased risk for breast cancer. OBJECTIVE To assess differences between placebo, estrogen, and three estrogen-progestin regimens on change in mammographic density. DESIGN Subset analysis of a 3-year, multicenter, double-blind, randomized, placebo-controlled trial. SETTING Seven ambulatory study center...

متن کامل

مقایسه تغییرات ماموگرافیک در دو نوع رژیم رایج هورمون درمانی جایگزین بعد از یائسگی

  Background & Objective : Nowadays breast cancer is one of the most causes of female mortality. Mammography is a valuable method for early detection of breast cancer. Mammographic sensitivity depends on some factors such as age, breast tissue density, menopausal status, systemic disease, familial history of breast cancer and others. This study was designed to compare the effects of two regimen...

متن کامل

The effect of transdermal testosterone on mammographic density in postmenopausal women not receiving systemic estrogen therapy.

CONTEXT Greater mammographic density is associated with increased breast cancer risk and reduced diagnostic mammographic sensitivity and may be seen with estrogen/progestin therapy (EPT). The effects of testosterone therapy on mammographic density in postmenopausal women not on EPT are not known. OBJECTIVE Our objective was to compare effects of two doses of the testosterone transdermal patch...

متن کامل

Influence of Estrogen Receptor A and Progesterone Receptor Polymorphisms on the Effects of Hormone Therapy on Mammographic Density

Postmenopausal hormone therapy increases mammographic density, a strong breast cancer risk factor, but effects vary across women. We investigated whether the effect of hormone therapy use is modified by polymorphisms in the estrogen receptor (ESR1) and progesterone receptor (PGR) genes in the Dutch Prospect-EPIC and the English EPICNorfolk cohorts. Information on hormone therapy use was obtaine...

متن کامل

Estrogen-plus-progestin use and mammographic density in postmenopausal women: Women's Health Initiative randomized trial.

BACKGROUND Increased mammographic density reduces the sensitivity of screening mammography, is associated with increased breast cancer risk, and may be hormone related. We assessed the effect of estrogen-plus-progestin therapy on mammographic density. METHODS In a racially and ethnically diverse ancillary study of the Women's Health Initiative, we examined data from 413 postmenopausal women w...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

عنوان ژورنال:
  • Menopause

دوره 19 3  شماره 

صفحات  -

تاریخ انتشار 2012